Skip to main content
Fig. 2 | BMC Nephrology

Fig. 2

From: Mineral and bone disorder management in hemodialysis patients: comparing PTH control practices in Japan with Europe and North America: the Dialysis Outcomes and Practice Patterns Study (DOPPS)

Fig. 2

Prescription of PTH-lowering therapies by region and dialysis vintage. The figure shows any prescription of active vitamin D or cinacalcet over the subsequent 9 month run-in period, by region [Europe/Australia/New Zealand (Eur/ANZ), North America and Japan] and dialysis vintage at DOPPS enrollment (< 90 days, 90 days-1 year and > 1 year)

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us